61 investors have funded 18 Life Sciences companies head-officed in Charlottesville, across 85 rounds (Sep 2009 – Sep 2023). They are ranked by how many Charlottesville companies in this market they have actually backed.
"In Charlottesville" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | Center for Innovative Technology | Herndon, United States | SeedSeries A | 6 | 8 | 2 | Jun 2017 | 124 |
| 2 | University of Virginia | Charlottesville, United States | Series BSeedSeries C | 3 | 4 | 1 | Dec 2022 | 7 |
| 3 | IrishAngels | Chicago, United States | Series A | 2 | 2 | 2 | May 2018 | 37 |
| 4 | VTC Innovation Fund | Roanoke, United States | Series BSeed | 2 | 2 | — | Jan 2021 | 5 |
| 5 | Afton Scientific | Charlottesville, United States | Series ASeed | 2 | 2 | — | Jun 2016 | 2 |
| 6 | Rhia Ventures | San Francisco, United States | Series A | 1 | 3 | 1 | Nov 2022 | 15 |
| 7 | Grotech Ventures | Arlington, United States | Series BSeries A | 1 | 2 | 1 | Jun 2011 | 125 |
| 8 | Pfizer | New York City, United States | SeedSeries A | 1 | 2 | 2 | Feb 2015 | 110 |
| 9 | Longitude Capital | Menlo Park, United States | Series ASeries B | 1 | 2 | 1 | Sep 2022 | 84 |
| 10 | Metaplanet | Tallinn, Estonia | Series A | 1 | 2 | — | Nov 2022 | 70 |
| 11 | Medicxi | London, United Kingdom | Series BSeries A | 1 | 2 | 1 | Sep 2022 | 40 |
| 12 | Graphene Ventures | Palo Alto, United States | Series A | 1 | 2 | — | Nov 2022 | 36 |
| 13 | ShangBay Capital | Palo Alto, United States | Series A | 1 | 2 | — | Nov 2022 | 36 |
| 14 | MBX Capital | New York City, United States | Series A | 1 | 2 | 1 | Nov 2022 | 24 |
| 15 | RxCelerate | Babraham, United Kingdom | Series ASeries B | 1 | 2 | — | Sep 2022 | 1 |
| 16 | Y Combinator | Mountain View, United States | Seed | 1 | 1 | — | May 2016 | 5,648 |
| 17 | Google Ventures | Mountain View, United States | Series A | 1 | 1 | 1 | Nov 2022 | 736 |
| 18 | Founders Fund | San Francisco, United States | Series A | 1 | 1 | — | Oct 2021 | 543 |
| 19 | Kima Ventures | Paris, France | Seed | 1 | 1 | — | Jun 2016 | 636 |
| 20 | RA Capital Management | Boston, United States | Series B | 1 | 1 | 1 | Sep 2022 | 317 |
| 21 | Morningside | Series A | 1 | 1 | 1 | Sep 2019 | 171 | |
| 22 | 5Y Capital | Shanghai, China | Series A | 1 | 1 | 1 | Sep 2019 | 154 |
| 23 | Novartis Venture Fund | Basel, Switzerland | Series A | 1 | 1 | 1 | Jan 2017 | 139 |
| 24 | Janus Henderson Investors | London, United Kingdom | Series D | 1 | 1 | — | Feb 2021 | 164 |
| 25 | LaunchCapital | New Haven, United States | Series A | 1 | 1 | — | Nov 2015 | 113 |
| 26 | Arboretum Ventures | Ann Arbor, United States | Series C | 1 | 1 | 1 | Dec 2022 | 65 |
| 27 | Harbert Management | Birmingham, United States | Series B | 1 | 1 | 1 | Jun 2011 | 74 |
| 28 | Adage Capital Management | Boston, United States | Series D | 1 | 1 | — | Feb 2021 | 87 |
| 29 | Seedfund | Mumbai, India | Series B | 1 | 1 | — | Mar 2019 | 46 |
| 30 | Bain Capital Life Sciences | Boston, United States | Series B | 1 | 1 | — | Sep 2022 | 51 |
| 31 | Lilly Ventures | Indianapolis, United States | Series A | 1 | 1 | 1 | Jan 2017 | 40 |
| 32 | Epidarex Capital | Bethesda, United States | Seed | 1 | 1 | 1 | Jan 2021 | 25 |
| 33 | Partners Health Care Innovation | Cambridge, United States | Series A | 1 | 1 | 1 | Sep 2019 | 18 |
| 34 | Angelini Ventures | Rome, Italy | Seed | 1 | 1 | 1 | Oct 2021 | 22 |
| 35 | New Dominion Angels | Warrenton, United States | Series A | 1 | 1 | — | Jul 2012 | 19 |
| 36 | Genoa Ventures | San Francisco, United States | Series C | 1 | 1 | 1 | Dec 2022 | 19 |
| 37 | 3B Future Health Fund | Monaco, Monaco | Seed | 1 | 1 | 1 | Oct 2021 | 19 |
| 38 | BB Biotech | Schaffhausen, Switzerland | Series B | 1 | 1 | — | Sep 2022 | 17 |
| 39 | Eshelman Ventures | Wilmington, United States | Series A | 1 | 1 | 1 | Feb 2015 | 12 |
| 40 | Suvretta Capital Management | New York City, United States | Series D | 1 | 1 | 1 | Feb 2021 | 12 |
| 41 | Amboy Street Ventures | Los Angeles, United States | Series A | 1 | 1 | — | Nov 2022 | 10 |
| 42 | Main Line Equity Partners | Ardmore, United States | Series A | 1 | 1 | — | Sep 2012 | 12 |
| 43 | KOFA Healthcare Investments | West Lafayette, United States | Series A | 1 | 1 | 1 | May 2018 | 9 |
| 44 | Enso Ventures | Mayfair, United Kingdom | Series A | 1 | 1 | — | Jan 2017 | 8 |
| 45 | Medvest Capital | West Palm Beach, United States | Series B | 1 | 1 | 1 | Mar 2019 | 5 |
| 46 | Felton Group | Wallkill, United States | Series C | 1 | 1 | — | Dec 2022 | 6 |
| 47 | Piedmont Angel Network | Winston-salem, United States | Series A | 1 | 1 | — | Jul 2012 | 5 |
| 48 | Santen Pharmaceuticals | Osaka, Japan | Series A | 1 | 1 | — | Nov 2015 | 6 |
| 49 | Pharmstandard | Moscow, Russia | Series B | 1 | 1 | — | Dec 2017 | 5 |
| 50 | Piedmont Investment Advisors | Durham, United States | Series A | 1 | 1 | — | Jul 2012 | 4 |
| 51 | MooDoos | San Diego, United States | Series A | 1 | 1 | — | Jul 2012 | 4 |
| 52 | Ludicrous Ventures | Series A | 1 | 1 | — | 3 | ||
| 53 | Keystone Capital Partners | New York City, United States | Post-IPO | 1 | 1 | — | Mar 2021 | 3 |
| 54 | Kids Connect Charitable Fund | Seed | 1 | 1 | — | Oct 2021 | 1 | |
| 55 | Malvern Panalytical | Almelo, Netherlands | Series B | 1 | 1 | 1 | Sep 2023 | 1 |
| 56 | Virgaventures.com | Series A | 1 | 1 | — | Jul 2012 | 1 | |
| 57 | i.Lab | Seed | 1 | 1 | — | Jun 2015 | 1 | |
| 58 | Capital Growth Medvest | Birmingham, United States | Series C | 1 | 1 | — | Dec 2022 | 1 |
| 59 | Smith Ventures | Series A | 1 | 1 | — | Oct 2021 | 1 | |
| 60 | PharmaDirections | Cary, United States | Seed | 1 | 1 | — | Jan 2021 | 1 |
| 61 | PDI Ventures | Loganville | Seed | 1 | 1 | — | Oct 2021 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Charlottesville that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Contraline contraline.com |
13 | 19 | $126.7M | Series A Nov 2022 |
| BrightSpec brightspec.com |
7 | 8 | $98.9M | Series C Dec 2022 |
| Rivus Pharmaceuticals rivuspharma.com |
6 | 9 | $897M | Series B Sep 2022 |
| Phthisis Diagnostics phthisisdiagnostics.com |
6 | 6 | $2.5M | Series A Jul 2012 |
| TearSolutions tearsolutions.com |
5 | 5 | $26M | Series B Dec 2017 |
| GenEp genepbio.com |
5 | 5 | $7.3M | Seed Oct 2021 |
| HemoShear Therapeutics hemoshear.com |
4 | 4 | $129.3M | Series D Feb 2021 |
| Cavion cavionpharma.com |
4 | 4 | $78.3M | Series A Jan 2017 |
| ZielBio zielbio.com |
4 | 5 | $76.5M | Series A Sep 2019 |
| Neoantigenics neoantigenics.com |
4 | 6 | $12.3M | Series A Feb 2015 |
| Slate Bio slatebio.com |
4 | 4 | $7M | Seed Jan 2021 |
| OpenQ openq.com |
2 | 3 | $13.5M | Series B Jun 2011 |
| Caretaker caretakermedical.net |
2 | 2 | $6.8M | Series A May 2018 |
| LumaCyte lumacyte.com |
1 | 1 | $13M | Series B Sep 2023 |
| Adial Pharmaceuticals adial.com |
1 | 1 | $2.1M | Post-IPO Mar 2021 |
| SphynKx Therapeutics sphynkx.com |
1 | 1 | $50K | Seed Jan 2012 |
| PhosImmune phosimmune.com |
1 | 1 | — | Seed Aug 2014 |
| TypeZero Technologies typezero.com |
1 | 1 | — | Seed Jun 2015 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Sep 2023 | Malvern PanalyticalLED | LumaCyte | Series B | $13M |
| Dec 2022 | Arboretum VenturesLED | BrightSpec | Series C | $18.4M |
| Dec 2022 | University of Virginia | BrightSpec | Series C | $18.4M |
| Dec 2022 | Felton Group | BrightSpec | Series C | $18.4M |
| Dec 2022 | Capital Growth Medvest | BrightSpec | Series C | $18.4M |
| Dec 2022 | Genoa VenturesLED | BrightSpec | Series C | $18.4M |
| Nov 2022 | Google VenturesLED | Contraline | Series A | $7.2M |
| Nov 2022 | MBX Capital | Contraline | Series A | $7.2M |
| Nov 2022 | ShangBay Capital | Contraline | Series A | $7.2M |
| Nov 2022 | Graphene Ventures | Contraline | Series A | $7.2M |
| Nov 2022 | Metaplanet | Contraline | Series A | $7.2M |
| Nov 2022 | Rhia Ventures | Contraline | Series A | $7.2M |
| Nov 2022 | Amboy Street Ventures | Contraline | Series A | $7.2M |
| Sep 2022 | RA Capital ManagementLED | Rivus Pharmaceuticals | Series B | $132M |
| Sep 2022 | Longitude Capital | Rivus Pharmaceuticals | Series B | $132M |
| Sep 2022 | BB Biotech | Rivus Pharmaceuticals | Series B | $132M |
| Sep 2022 | RxCelerate | Rivus Pharmaceuticals | Series B | $132M |
| Sep 2022 | Bain Capital Life Sciences | Rivus Pharmaceuticals | Series B | $132M |
| Sep 2022 | Medicxi | Rivus Pharmaceuticals | Series B | $132M |
| Oct 2021 | University of VirginiaLED | GenEp | Seed | $1.5M |
Life Sciences investors in other cities
Other markets in Charlottesville